Epoch BiodesignTotal BioDesign is based in London, UK.TM Funding raised by company for $11M from seed capital
Lowercarbon Capital led the round, which included participation from BoxGroup and Amadeus Capital Partners as well as Zero Carbon capital, Zero Carbon capital, Zero Carbon capital, Zero Carbon capital, VOYAGERS Climate-Tech Fund and The Venture Collective.
The company intends to use the funds for the expansion of its protein design platform, construction of new R&D facilities and further development and scale up of their first solution.
Epoch Biodesign’s CEO Jacob Nathan is responsible for developing natural solutions to unnatural problems. The company has the mission of industrializing biology for a healthy planet. Epoch uses a combination of experimental and computational tools to advance biorecycling, a process that transforms plastic waste into common chemicals.
About Epoch Biodesign